Early Stage Drug Development Company
We’re a high value-added company that applies photoisomerization conversion technology
Financial Information
Total Assets
Unit:1,000 KRW
| Y2019 | Y2020 | Y2021 |
|---|---|---|
| 3,694,792 | 4,082,386 | 4,302,102 |
Total Liabilities
Unit:1,000 KRW
| Y2019 | Y2020 | Y2021 |
|---|---|---|
| 1,759,318 | 2,125,968 | 2,323,913 |
Equity
Unit:1,000 KRW
| Y2019 | Y2020 | Y2021 |
|---|---|---|
| 1,110,242 | 1,110,242 | 1,110,242 |
Total Equity
Unit:1,000 KRW
| Y2019 | Y2020 | Y2021 |
|---|---|---|
| 1,935,474 | 1,956,418 | 1,978,189 |